Oncology Industry
Insights & Trends
June 24, 2025
The Evolving Therapeutic Landscape of Hematologic Malignancies What’s Now and What’s Next Hematologic malignancies: multiple myeloma, leukemia and lymphoma—have long posed complex challenges in oncology. However, […]
May 28, 2025
AI is Transforming Oncology Drug Development — and How Kognitic Empowers You to Stay Ahead The landscape of oncology drug development is undergoing a seismic shift. […]
May 24, 2021
COVID Vaccines, what’s new: an update on the latest clinical trials that are underway with the currently administered vaccines The global pandemic posed a challenge for […]
February 23, 2021
This week we saw two major deals in the ADC landscape of oncology: Gilead acquired Immunomedic’s Trop2-directed Trodelvy in a $21B deal, giving the company […]
September 12, 2020
We were deeply saddened to learn of Chadwick Boseman’s passing after a four year battle with colorectal cancer. Chadwick inspired and entertained millions through his portrayal […]
May 1, 2020
ACTT Trial Results Indicate Remdesivir’s Efficacy Against Covid-19 The National Institutes of Health released interim #data from the Phase 3 ACTT trial, which explores #remdesivir for […]
May 1, 2020
#Takeda has added a #Covid19 Expansion arm to their phase 1 trial exploring the small molecule TAK-981 in solid tumors and hematologic malignancies. As this #pandemic […]
April 30, 2020
#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]
April 29, 2020
#Kognitic has made it our mission to make #Covid19 clinical research publicly accessible. True accessibility not only requires data, but the knowledge necessary to interpret that […]